Identification |
Name: | 2-Pyridinesulfonamide,N-[3-[(1R)-1-[(6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)- |
Synonyms: | 2-Pyridinesulfonamide,N-[3-[1-[5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-,[R-(R*,R*)]-;Aptivus;PNU 140690;Tipranavir;U 140690; |
CAS: | 174484-41-4 |
Molecular Formula: | C31H33F3N2O5S |
Molecular Weight: | 602.66 |
InChI: | InChI=1/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,36-37H,3-4,15-17,19H2,1-2H3/t25-,30-/m1/s1 |
Molecular Structure: |
|
Properties |
Melting Point: | 86-890C |
Density: | 1.313g/cm3 |
Refractive index: | 1.579 |
Appearance: | White Solid |
Usage: | Nonpeptidic HIV protease inhibitor (NPPI). Antiviral |
Safety Data |
|
|